Consider Holding Febuxostat in Patients Admitted with CV Disease

September 2018

Please see the February 2019 FDA advisory concerning the increased risk of death with Uloric (Febuxostat)....

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

Antibiotics Don't Expect the New Antibiotic Plazomicin to Be Added to Formulary
Thrombolytics Weigh Thrombolytic Pros and Cons for Submassive Pulmonary Embolism
Bites Stings Know the Difference Between CroFab and the New Snakebite Antivenom Anavip
Recalls The Valsartan Recall May Shake Up ARB Use at Your Hospital
Antibiotics Continue to Avoid Quinolones When Possible
New Drugs Stick With Clonidine When Using a Non-Opioid to Manage Acute Opioid Withdrawal
Diabetes Don't Jump to Newer Diabetes Meds for Renal Protection Yet
New Drugs Watch for Epidiolex, a New Rx Cannabinoid
Gout Consider Holding Febuxostat in Patients Admitted with CV Disease
New Drugs Hold the Low-Dose Vaginal Estrogen Imvexxy During Hospitalization